July 13 (Reuters) - Abbott Laboratories (NYSE:ABT) ABT.N :
* ABBOTT AGREES TO GLOBAL TRANSCATHETER LITIGATION SETTLEMENT WITH EDWARDS LIFESCIENCES
* ABBOTT LABORATORIES - IN CONNECTION WITH THIS AGREEMENT, CO WILL RECEIVE A ONE-TIME PAYMENT AND ONGOING PAYMENTS BASED ON PASCAL SALES THROUGH 2025
* ABBOTT LABORATORIES - RELATED TO EDWARDS LIFESCIENCES AGREEMENT, CO WILL ALSO RECEIVE POTENTIAL SALES MILESTONE PAYMENT IN 2026